Renaissance Technologies’s Beam Therapeutics BEAM Stock Holding History

Renaissance Technologies’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.2M	Buy	513,578 +357,078	+228%	+$9.91M	0.02%	868
2025 Q4	$4.34M	Buy	+156,500	New	+$3.99M	0.01%	1386
2025 Q2	–	Sell	-12,107	Closed	-$236K	–	3558
2025 Q1	$236K	Sell	12,107 -10,800	-47%	-$283K	﹤0.01%	3018
2024 Q4	$568K	Buy	+22,907	New	+$585K	﹤0.01%	2783
2023 Q1	–	Sell	-131,900	Closed	-$5.16M	–	3977
2022 Q4	$5.16M	Buy	131,900 +60,600	+85%	+$2.71M	0.01%	1506
2022 Q3	$3.4M	Sell	71,300 -208,600	-75%	-$11.9M	﹤0.01%	1685
2022 Q2	$10.8M	Buy	+279,900	New	+$11.1M	0.01%	1072
2021 Q3	–	Sell	-16,500	Closed	-$2.12M	–	3475
2021 Q2	$2.12M	Sell	16,500 -21,600	-57%	-$1.72M	﹤0.01%	2217
2021 Q1	$3.05M	Buy	+38,100	New	+$3.62M	﹤0.01%	1955

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Renaissance Technologies's BEAM Position: Q1 2026 in Review

Renaissance Technologies increased its Beam Therapeutics (BEAM) stake by 228% in Q1 2026, buying an estimated $9.91M and bringing the position to 513,578 shares worth $12.2M. The position accounts for 0.02% of the portfolio, ranked #868.

Renaissance Technologies first reported a position in BEAM in Q1 2021 and has held it in 9 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Renaissance Technologies held 513,578 shares of Beam Therapeutics worth $12.2M as of Q1 2026.
Renaissance Technologies bought 357,078 Beam Therapeutics shares in Q1 2026, an estimated $9.91M.
Beam Therapeutics made up 0.02% of Renaissance Technologies's portfolio in Q1 2026, its #868 holding.
Renaissance Technologies first reported a position in Beam Therapeutics in Q1 2021 and has held it in 9 quarters since.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.